Late-breaking Diabetes & Glucose Metabolism II (posters)

LBF-097

28-Day Continuous Glucose Profiles Via Implantable Telemetry in Mice
Robert V Brockway, Kimberly L Holliday-White, Heather M Bogie, Kathryn E Lillegard and Justin Van Hee

LBF-098

Association Between Increased Soluble Receptor Activator of Nuclear Factor- Κβ Ligand in Subjects with Prediabetes
Gokcen Kocabas, Mehmet Yavuz, Mehmet Calan, Belma Gokcen, Murat Aksit, Giray Bozkaya and Oktay Bilgir

LBF-099

Why Technology Use Fades in a Real World Setting
Eun Kyung Koh and Dace Trence

LBF-100

Is Higher Glycemic Variability in Type 2 Diabetes Patients Associated with Reduced Quality of Life?
Wendela de Ranitz-Greven, Joline Beulens, Douwe Biesma, Bianca Silvius, Marloes Bons and Harold Wessel De Valk

LBF-102

Differences of Glycolysis in Septic Patients According to Shock Resolution Status
Ioannis Ilias, Sofia Apollonatou, Nikitas Nikitas, Maria Theodorakopoulou, Frantzeska Frantzeskaki, Dimitra Vasiliadi and Ioanna Dimopoulou

LBF-103

LBF-104

Assessing the Efficacy of A1C, Fructosamine and Glycated Albumin in Detecting Abnormal Glucose Tolerance: The Africans in America Study
Michelle T Duong, Caroline K Thoreson, Stephanie T Chung, Paola C Aldana, Madia Ricks, Lilian Mabundo, David Barry Sacks and Anne E Sumner

LBF-106

Predicting Autoimmune Diabetes in Minority Diabetic Populations
Kristina Djekic, Yang Lu, Pauline Genter, Yii-Der Ida Chen, Jerome Rotter and Eli Ipp

LBF-107

A Novel Treatment of Type 2 Diabetes By Regulating Liver, Spleen and Kidney Together
Sihua Gao, Dandan Zhao, Xiaoke Li, Xin Fang, Qianqian Mu, Fangfang Mo and Dongwei Zhang

LBF-109

Change in Glycemic Control in Youth with Type 2 Diabetes (T2DM):  Search for Diabetes in Youth and Prospective Diabetes Follow-up Registry (DPV) Cohorts
Catherine Pihoker, Dana M Dabelea, Daniel P Beavers, Jean M Lawrence, Thomas Meissner, Thomas Michael Kapellen, Thomas Reinehr, Edith Schober, Susanna Wiegand, Maria Fritsch and Reinhard W. Holl

LBF-110

In silico Clones of Cardiovascular Surgical Patients: A First Step Toward Simulation-Based Insulin Protocol Optimization for This Patient Population
Anthony L. McCall, E. Andy Ortiz, Jennifer Mason Lobo, Leon S Farhy, Jennifer L. Kirby, James M. Isbell and Stephen D. Patek

LBF-112

Sitagliptin Reduces Markers of Inflammation and Chronic Immune Cell Activation in HIV+ Adults with Glucose Intolerance
Conor Best, Heidi Struthers, Erin Laciny, Paige Kuhlman, Mark A Ziegler, Michael Royal, Dominic Nicholas Reeds and Kevin Edward Yarasheski